To determine whether hepatic SERCA2 mediates the beneficial effects of AT-II in combating fatty liver, we performed hepatic Serca2 knockdown in DIO mice by injecting the AAV8 virus via the tail vein (Fig. 9A). The gene discussed is ATP2A2; the disease is fatty liver disease.